Literature DB >> 9741638

Immune mediated and inherited defences against flaviviruses.

M A Brinton1, I Kurane, A Mathew, L Zeng, P Y Shi, A Rothman, F A Ennis.   

Abstract

BACKGROUND: Flavivirus infection elicits an abundant immune response in the host which is directed against a number of the viral proteins. Resistance to flavivirus-induced disease can also be controlled via a non-immune mechanism involving the product of a naturally occurring murine gene, Flv.
OBJECTIVES: To review studies that have reported the mapping of epitopes on flavivirus proteins that elicit T- or B-cell immune responses in mice or humans and to discuss a possible mechanism for flavivirus-specific genetic resistance. STUDY
DESIGN: Purified viral proteins and synthetic peptides were used to map B-cell epitopes. Purified proteins, vaccinia-expressed viral protein fragments and synthetic peptides were used to map T-cell epitopes. Congenic-resistant, C3H/RV and congenic susceptible, C3H/He mice and cell cultures were used to study the mechanism of genetic resistance to flavivirus infection.
RESULTS: T- and B-cell epitopes have been mapped to the E, NS1 and NS3 proteins of several flaviviruses. Immune responses to the C, PreM, NS2a, NS4a, and NS5 proteins have also been documented. Data suggest that the Flv gene product acts intracellularly to suppress the synthesis of viral genomic RNA.
CONCLUSIONS: Although flavivirus infection elicits an abundant immune response, this response is not always rapid enough to protect the host from developing encephalitis. During secondary infections both the humoral and cellular flavivirus-specific responses can confer protection. Dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS) appear to be caused by an overly vigorous immune response. In genetically resistant animals reduced production of virus results in a slower spread of the infection, which in turn allows time for the immune response to develop and to clear the infection before disease symptoms appear.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741638     DOI: 10.1016/s0928-0197(98)00039-7

Source DB:  PubMed          Journal:  Clin Diagn Virol        ISSN: 0928-0197


  13 in total

1.  Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections.

Authors:  Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  West nile virus: current perspectives.

Authors:  Om Prakash; George Pankey
Journal:  Ochsner J       Date:  2003

3.  Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.

Authors:  Kerrie Vaughan; Jason Greenbaum; Martin Blythe; Bjoern Peters; Alessandro Sette
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

Review 4.  A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies.

Authors:  Muhammad Faheem; Ummar Raheel; Muhammad Nasir Riaz; Naghmana Kanwal; Farakh Javed; Najam us Sahar Sadaf Zaidi; Ishtiaq Qadri
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

5.  Dengue virus selectively induces human mast cell chemokine production.

Authors:  Christine A King; Robert Anderson; Jean S Marshall
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay.

Authors:  Susan J Wong; Valerie L Demarest; Rebekah H Boyle; Tian Wang; Michel Ledizet; Kalipada Kar; Laura D Kramer; Erol Fikrig; Raymond A Koski
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

7.  Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.

Authors:  Jennifer Schepp-Berglind; Min Luo; Danher Wang; Jason A Wicker; Nicholas U Raja; Brian D Hoel; David H Holman; Alan D T Barrett; John Y Dong
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

8.  Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines.

Authors:  Simone M Costa; Anna Paula Yorio; Antônio J S Gonçalves; Mariana M Vidale; Emmerson C B Costa; Ronaldo Mohana-Borges; Marcia A Motta; Marcos S Freire; Ada M B Alves
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

9.  Large-scale analysis of antigenic diversity of T-cell epitopes in dengue virus.

Authors:  Asif M Khan; A T Heiny; Kenneth X Lee; K N Srinivasan; Tin Wee Tan; J Thomas August; Vladimir Brusic
Journal:  BMC Bioinformatics       Date:  2006-12-18       Impact factor: 3.169

Review 10.  Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex.

Authors:  Jody Hobson-Peters
Journal:  J Biomed Biotechnol       Date:  2012-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.